News

Video

Looking Out for Side Effects in Immunotherapy Combination Treatment

Immunotherapy in combination with chemotherapy is becoming a popular treatment for patients with lung cancer, but patients need to understand the side effects.

Immunotherapy in combination with chemotherapy brings on more side effects during treatment, however, serious side effects in combination treatment remain similar to side effects in chemotherapy alone, according to Nagashree Seetharamu, MD, MBBS.

At the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® Seetharamu, associate professor in Clinical Medicine at Hofstra and Northwell Health, presented on the benefits and challenges for immunotherapy and chemotherapy combination treatment for patients with lung cancer. Seethearamu also sat with CURE to discuss the side effect realities of this combination treatment and why patients must remain vigilant as they undergo the combination therapy.

TRANSCRIPTION

You have immunotherapy with its own set of side effects. They're not overlapping, meaning that they don't cause the same type of side effects, for the most part, the immunotherapy causes side effects by an overactive immune system. When the immune cells that we are trying to activate or trying to get stronger to attack the cancer cells, may sometimes attack one's own body, that's where the side effects come.

When you do the two together, the side effects are numerically more, but the serious side effects are not that very different in the two groups, patients receiving chemotherapy alone versus patients receiving chemotherapy plus immunotherapy.

The one message I give to patients on immunotherapy, whether by itself or in combination with chemotherapy, is to make a note of anything that is not normal for them from the time they start the treatment. If there is anything new that happens, I don't want them to be guessing whether is it a side effect? Or is it something that I ate yesterday? I would not want them to guess, I want them to give the information to me and let me do the guessing because these side effects with immunotherapy are reversible if it's tackled in a timely fashion.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.